All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @reytone_0001 on TikTok · 12s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @reytone_0001's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00You'll have to do chest clap or neck clap or chin.
  2. 0:04Yeah.
  3. 0:05You'll have to do chest clap or neck clap or chin.
  4. 0:09Yeah.

@reytone_0001's Men's Health TRT claims, fact-checked

sternocleidomastoid

TikTok creator

14.5K viewsWatch on TikTok

Quick answer

The transcript appears to reference alternative injection site locations, possibly for intramuscular or subcutaneous testosterone administration, but provides no clinical justification for neck or chin sites, which carry significant vascular and neurological risk. Standard TRT injection protocols supported by Endocrine Society guidelines recommend ventrogluteal, vastus lateralis, or deltoid sites for IM injection, and abdominal or gluteal subcutaneous tissue for subQ administration. Patients should consult their prescribing clinician before altering injection sites.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @reytone_0001's Men's Health TRT claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@reytone_0001's Men's Health TRT claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@reytone_0001's Men's Health TRT claims, fact-checked" from sternocleidomastoid. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The transcript appears to reference alternative injection site locations, possibly for intramuscular or subcutaneous testosterone administration, but provides no clinical justification for neck or chin sites, which carry significant vascular and neurological risk.

The reason this review is not generic is the source wording and the canonical claim label "trt thank you once again men s health mag hudsonwilliams fyp." In this clip, the useful excerpt is: "You'll have to do chest clap or neck clap or chin." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Subcutaneous testosterone injections are supported by Spratt et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The transcript appears to reference alternative injection site locations, possibly for intramuscular or subcutaneous testosterone administration, but provides no clinical justification for neck or chin sites, which carry significant vascular and neurological risk.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The transcript appears to reference alternative injection site locations, possibly for intramuscular or subcutaneous testosterone administration, but provides no clinical justification for neck or chin sites, which carry significant vascular and neurological risk. Standard TRT injection protocols supported by Endocrine Society guidelines recommend ventrogluteal, vastus lateralis, or deltoid sites for IM injection, and abdominal or gluteal subcutaneous tissue for subQ administration. Patients should consult their prescribing clinician before altering injection sites.
  • Endocrine Society guidelines (Bhasin et al., 2018, JCEM) name ventrogluteal, vastus lateralis, and deltoid as the accepted intramuscular testosterone injection sites, not chest, neck, or chin.
  • Subcutaneous testosterone injections are supported by Spratt et al. (2021, Andrology), which found comparable serum testosterone levels versus IM, using abdominal or upper gluteal fat tissue only.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Endocrine Society guidelines (Bhasin et al., 2018, JCEM) name ventrogluteal, vastus lateralis, and deltoid as the accepted intramuscular testosterone injection sites, not chest, neck, or chin.
  • Subcutaneous testosterone injections are supported by Spratt et al. (2021, Andrology), which found comparable serum testosterone levels versus IM, using abdominal or upper gluteal fat tissue only.
  • Neck injections of any oil-based substance risk carotid artery damage, jugular vein injury, and oil embolism; no legitimate TRT protocol has ever recommended this site.
  • The pectoral (chest) site has informal off-label use in some communities but has not been evaluated in controlled studies for testosterone pharmacokinetics or safety.
  • Consumer fitness magazines, including Men's Health, are not appropriate sources for injection technique guidance on a regulated medication like testosterone cypionate or enanthate.
  • Patients on self-injection TRT protocols should receive formal injection training from their prescribing clinician, including site selection, needle gauge, volume limits, and aspiration protocol.
  • Social media TRT content lacks the clinical context needed to safely apply technique advice; a 15-second clip cannot convey anatomical contraindications or individual patient risk factors.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @reytone_0001 actually say?

Honestly, it's hard to know. The transcript gives us: "You'll have to do chest clap or neck clap or chin." That's it, repeated twice. There's no context, no explanation of what "clapping" refers to, and no connection made to TRT or testosterone therapy explicitly in the spoken words. The video was tagged under TRT content and credits Men's Health magazine, which gives us some directional clues, but the actual claim here is frustratingly opaque.

The most charitable read is that the creator is referencing injection site selection for testosterone cypionate or enanthate, where the chest (pectoral), neck, or chin area might be mentioned in some informal or fringe context. Another interpretation is that this refers to subcutaneous or intramuscular injection site alternatives. Without more audio or visual context, we're working with a fragment. We'll evaluate what we can, but this one required significant inference.

Does the science back this up?

If this is about injection sites, the short answer is: not for the neck or chin, and only marginally for the chest. The evidence base for TRT injection sites is pretty clear about where to go and where not to go.

Standard intramuscular injection sites for testosterone cypionate and enanthate include the ventrogluteal, vastus lateralis (outer thigh), and deltoid muscles. These are backed by clinical guidelines from the Endocrine Society (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). Subcutaneous injection into abdominal or upper glute fat tissue has also gained traction, with Spratt et al. (2021, Andrology) demonstrating comparable bioavailability and patient-reported tolerability.

The neck and chin region? There is no peer-reviewed evidence supporting testosterone injections there. These areas carry serious neurovascular risk. The chest (pectoral region) is occasionally discussed in bodybuilding subcultures but is not a guideline-recommended site for medical TRT.

What did they get wrong (or right)?

If the creator is suggesting neck or chin as injection sites, that's wrong, and it could be genuinely dangerous. The neck contains the carotid artery, jugular vein, and multiple cranial nerve branches. Injecting anything near that region without clinical training is a serious risk for vascular injury, nerve damage, or systemic oil embolism. No legitimate TRT protocol recommends this.

To give credit where it's due: the chest (pectoral) has some informal use as a subcutaneous depot site, and a small number of clinical anecdotes exist. But it remains off-label, unstudied at scale, and not recommended by any major endocrinology body. If Men's Health published guidance pointing toward neck or chin injections, that would be a significant editorial failure on their part, and patients should not follow it.

The broader problem here is that social media TRT content, even when well-intentioned, compresses complex clinical decisions into 15-second clips with no room for safety nuance. That's a structural issue, not just a @reytone_0001 problem.

What should you actually know?

Injection site selection for TRT is a clinical decision, not a DIY experiment. Here's what the evidence actually supports:

  • Ventrogluteal (hip) injections are considered the gold standard for intramuscular testosterone by most clinical protocols, due to lower risk of sciatic nerve proximity compared to the dorsogluteal site (Small, 2004, Journal of Advanced Nursing).
  • Subcutaneous injections into abdominal fat or upper buttock tissue are increasingly used and have demonstrated comparable testosterone serum levels in multiple studies (Spratt et al., 2021, Andrology).
  • Deltoid injections are acceptable for smaller volumes (0.5-1 mL) but carry more variability in absorption.
  • Neck, chin, and face are never appropriate sites for self-administered testosterone injections. Period. No clinical evidence exists for this, and the anatomical risks are not theoretical.
  • If you're on a regulated TRT protocol, your prescribing provider should be walking you through injection training. If they haven't, ask. If they refuse, find a different provider.

The Men's Health credit in the caption adds a layer of concern. Consumer fitness media is not a substitute for clinical guidance, and crediting a magazine for medical technique advice is a pattern worth being skeptical of.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

sternocleidomastoid · TikTok creator

14.5K views on this video

thank you, once again Men's Health Mag #hudsonwilliams #fypシ゚viral #fyp #ineedhim #fyp

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about endocrine society guidelines (bhasin et al., 2018, jcem) name ventrogluteal,?

Endocrine Society guidelines (Bhasin et al., 2018, JCEM) name ventrogluteal, vastus lateralis, and deltoid as the accepted intramuscular testosterone injection sites, not chest, neck, or chin.

What does the video say about subcutaneous testosterone injections?

Subcutaneous testosterone injections are supported by Spratt et al. (2021, Andrology), which found comparable serum testosterone levels versus IM, using abdominal or upper gluteal fat tissue only.

What does the video say about neck injections of any oil-based substance risk carotid artery damage,?

Neck injections of any oil-based substance risk carotid artery damage, jugular vein injury, and oil embolism; no legitimate TRT protocol has ever recommended this site.

What does the video say about the pectoral (chest) site has informal off-label use in some?

The pectoral (chest) site has informal off-label use in some communities but has not been evaluated in controlled studies for testosterone pharmacokinetics or safety.

What does the video say about consumer fitness magazines, including men's health,?

Consumer fitness magazines, including Men's Health, are not appropriate sources for injection technique guidance on a regulated medication like testosterone cypionate or enanthate.

What does the video say about patients on self-injection trt protocols should receive formal injection training?

Patients on self-injection TRT protocols should receive formal injection training from their prescribing clinician, including site selection, needle gauge, volume limits, and aspiration protocol.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by sternocleidomastoid, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.